News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Lannett Company, Inc. Announces Chief Financial Officer Resignation
August 3, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Keith Ruck has resigned as chief financial officer to pursue other interests. The company expects to name a successor shortly.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
FDA
FDA taps Szarama as acting CBER director as Prasad’s tumultuous tenure ends
May 1, 2026
·
2 min read
·
Heather McKenzie
Earnings
Merck drops early-stage TROP ADC, keeps deal doors open as Keytruda clock ticks
April 30, 2026
·
5 min read
·
Gabrielle Masson
Earnings
Lilly’s weight loss pill reaches brand new patients, even without full-court marketing press
April 30, 2026
·
3 min read
·
Annalee Armstrong
Earnings
BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout
April 30, 2026
·
2 min read
·
Tristan Manalac